Overcoming or circumventing the stratum corneum barrier for efficient transcutaneous immunization
被引:49
作者:
Chen, Zhongjian
论文数: 0引用数: 0
h-index: 0
机构:
Shanghai Dermatol Hosp, Shanghai 200443, Peoples R ChinaShanghai Dermatol Hosp, Shanghai 200443, Peoples R China
Chen, Zhongjian
[1
]
Lv, Yongjiu
论文数: 0引用数: 0
h-index: 0
机构:
Fudan Univ, Sch Pharm, Key Lab Smart Drug Delivery MOE, Shanghai 201203, Peoples R China
PLA, Shanghai 201203, Peoples R ChinaShanghai Dermatol Hosp, Shanghai 200443, Peoples R China
Lv, Yongjiu
[2
,3
]
Qi, Jianping
论文数: 0引用数: 0
h-index: 0
机构:
Shanghai Dermatol Hosp, Shanghai 200443, Peoples R China
Fudan Univ, Sch Pharm, Key Lab Smart Drug Delivery MOE, Shanghai 201203, Peoples R China
PLA, Shanghai 201203, Peoples R ChinaShanghai Dermatol Hosp, Shanghai 200443, Peoples R China
Qi, Jianping
[1
,2
,3
]
Zhu, Quangang
论文数: 0引用数: 0
h-index: 0
机构:
Shanghai Dermatol Hosp, Shanghai 200443, Peoples R ChinaShanghai Dermatol Hosp, Shanghai 200443, Peoples R China
Zhu, Quangang
[1
]
Lu, Yi
论文数: 0引用数: 0
h-index: 0
机构:
Shanghai Dermatol Hosp, Shanghai 200443, Peoples R China
Fudan Univ, Sch Pharm, Key Lab Smart Drug Delivery MOE, Shanghai 201203, Peoples R China
PLA, Shanghai 201203, Peoples R ChinaShanghai Dermatol Hosp, Shanghai 200443, Peoples R China
Lu, Yi
[1
,2
,3
]
Wu, Wei
论文数: 0引用数: 0
h-index: 0
机构:
Shanghai Dermatol Hosp, Shanghai 200443, Peoples R China
Fudan Univ, Sch Pharm, Key Lab Smart Drug Delivery MOE, Shanghai 201203, Peoples R China
PLA, Shanghai 201203, Peoples R ChinaShanghai Dermatol Hosp, Shanghai 200443, Peoples R China
Wu, Wei
[1
,2
,3
]
机构:
[1] Shanghai Dermatol Hosp, Shanghai 200443, Peoples R China
[2] Fudan Univ, Sch Pharm, Key Lab Smart Drug Delivery MOE, Shanghai 201203, Peoples R China
Transcutaneous immunization (TCI) is a promising alternative to vaccine delivery via the subcutaneous and intramuscular routes because of the unique immunological characteristics of the skin. However, the stratum corneum (SC) prevents entry of most therapeutic compounds into the body. Several physical devices have been developed to overcome the SC barrier, but still damage the skin. However, by targeting antigens to the abundant perifollicular antigen-presenting cells (APCs), the transfollicular route might be a promising approach for TCI without compromising the skin barrier.